{"id":251,"date":"2020-05-28T22:06:06","date_gmt":"2020-05-28T20:06:06","guid":{"rendered":"https:\/\/gollneritsch.at\/?page_id=251"},"modified":"2024-05-15T20:15:09","modified_gmt":"2024-05-15T18:15:09","slug":"gollneritsch-at-digital-healthcare-pharma-consulting-e-u","status":"publish","type":"page","link":"https:\/\/gollneritsch.at\/?page_id=251","title":{"rendered":"Pers\u00f6nliche Informationen"},"content":{"rendered":"\n<div class=\"wp-block-media-text alignwide is-stacked-on-mobile is-style-rounded\" style=\"grid-template-columns:25% auto\"><figure class=\"wp-block-media-text__media\"><img loading=\"lazy\" decoding=\"async\" width=\"683\" height=\"1024\" src=\"https:\/\/gollneritsch.at\/wp-content\/uploads\/2020\/05\/Wolfgang-Gollneritsch_2019-683x1024.jpg\" alt=\"\" class=\"wp-image-243 size-full\" srcset=\"https:\/\/gollneritsch.at\/wp-content\/uploads\/2020\/05\/Wolfgang-Gollneritsch_2019-683x1024.jpg 683w, https:\/\/gollneritsch.at\/wp-content\/uploads\/2020\/05\/Wolfgang-Gollneritsch_2019-200x300.jpg 200w, https:\/\/gollneritsch.at\/wp-content\/uploads\/2020\/05\/Wolfgang-Gollneritsch_2019-768x1152.jpg 768w, https:\/\/gollneritsch.at\/wp-content\/uploads\/2020\/05\/Wolfgang-Gollneritsch_2019-1024x1536.jpg 1024w, https:\/\/gollneritsch.at\/wp-content\/uploads\/2020\/05\/Wolfgang-Gollneritsch_2019.jpg 1080w\" sizes=\"auto, (max-width: 683px) 100vw, 683px\" \/><\/figure><div class=\"wp-block-media-text__content\">\n<ul class=\"wp-block-list\">\n<li>Alter: 55 (*09.01.1969)<\/li>\n\n\n\n<li>Beziehungsstatus: verheiratet (2 Kinder)<\/li>\n\n\n\n<li>Staatsb\u00fcrgerschaft: \u00d6sterreich<\/li>\n\n\n\n<li>Geburtsort: Wien<\/li>\n<\/ul>\n<\/div><\/div>\n\n\n\n<p class=\"has-green-color has-text-color has-medium-font-size\"><strong>Berufsbild<\/strong><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Manager der Pharmaindustrie mit strategischer Ausrichtung und operativer Erfahrung in den Bereichen Abteilungsleitung, Marketing\/Sales Management, Projektmanagement  und Operational Excellence.<\/li>\n\n\n\n<li>Umsatz- und Gewinnmaximierung des Produktportfolios, Leitung von nationalen und internationalen Projekten und Arbeitsgruppen zur Entwicklung und Umsetzung von kulturellen und strategisch\/operativen Unternehmenszielen mit interdisziplin\u00e4ren Teams und externen Partnern.<\/li>\n<\/ul>\n\n\n\n<p class=\"has-green-color has-text-color has-medium-font-size\"><strong>Meine Erfahrung umfasst insbesonders:<\/strong><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Entwicklung und Umsetzen von strategischen Bereichsvisionen und -zielen<\/li>\n\n\n\n<li>Entwicklung und Leitung effektiver und agiler Teams<\/li>\n\n\n\n<li>Leitung nationaler\/regionaler\/internationaler interdisziplin\u00e4rer und multidisziplin\u00e4rer Teams bez\u00fcglich Projektmanagement und Reporting.<\/li>\n\n\n\n<li>Effektive Steuerung von Entscheidungsprozessen<\/li>\n\n\n\n<li>Wahrnehmen der Moderatoren- bzw. Mediatorenrolle bei widerspr\u00fcchlichen Gruppeninteressen<\/li>\n\n\n\n<li>Umsetzung von Change-Management und Prozessoptimierung<\/li>\n<\/ul>\n\n\n\n<p class=\"has-green-color has-text-color has-medium-font-size\"><strong>Beruflicher Werdegang<\/strong><\/p>\n\n\n\n<figure class=\"wp-block-table\"><table><tbody><tr><td><strong>06\/2023-<\/strong><\/td><td><strong>Daiichi-Sankyo Europe, Evidence Generation (EG)<\/strong>, <strong>PMOE (Europe)<\/strong>; <strong><em>Project Manager <\/em><\/strong> <em>(Contractor)<\/em><br>Operational Excellence f\u00fcr das Center of Excellence\/Evidence Generation. Entwicklung, Implementierung und Optimierung von Business-Projekten.<\/td><\/tr><tr><td><strong>06\/2022-07\/2023<\/strong><\/td><td><strong>IBM\/Pfizer; <em>Bold Moves Team Lead<\/em><\/strong> <em><em> (Contractor)<\/em><\/em><br>Verantwortung f\u00fcr das Projektmanagement in der Implementierung von <strong><em>PfizerPro<\/em><\/strong> (digital engagement platform f\u00fcr HCP). Team Lead f\u00fcr 10 M\u00e4rkte im <strong><em>Global Team <\/em><\/strong>von Pfizer.<\/td><\/tr><tr><td><strong>09\/2020-05\/2023<\/strong><\/td><td><strong>Kwizda Pharma GmbH; <em>Brand Manager<\/em><\/strong> Verantwortung f\u00fcr Marketing, Market Access und Targeting TA Stoffwechsel.Pre-launch und Launch von Mysimba<sup>\u00ae <\/sup>(Naltrexon\/Bupropion).<\/td><\/tr><tr><td><strong>04\/2019-05\/2020<\/strong><\/td><td><strong>DSD-Pharma GmbH; <em>Medical Marketing Manager<\/em><\/strong> Verantwortung f\u00fcr Marketing, Medizin und Portfolioentwicklung.<strong><u><\/u><\/strong>Pre-launch und Launch von Syntroxine<sup>\u00ae <\/sup>(Thyroxin; IBSA), Iodopol-131<sup>\u00ae<\/sup> (131I; Polatom).<strong><u><\/u><\/strong><\/td><\/tr><tr><td><strong>04\/2018-03\/2019<\/strong><\/td><td><strong>Kyowa Kirin GmbH; <em>Senior Marketing &amp; Market Access Manager<\/em><\/strong> Verantwortung f\u00fcr Marketing, Market Access, Kundensegmentierung und Targeting.<strong><u><\/u><\/strong>Pre-launch und Erstattung von Crysvita<sup>\u00ae<\/sup> (Burosumab) zur Therapie der X-chromosomalen Hypophosphat\u00e4mie (XLH).<strong><u><\/u><\/strong><\/td><\/tr><tr><td><strong>02\/2011- 03\/2018<\/strong><\/td><td><strong>Vifor Pharma Austria, Wien; Marketing Director\/Head of Marketing<\/strong> Verantwortung f\u00fcr Marketing &amp; Corporate Communication. Implementierung &amp; Durchf\u00fchrung von Targeting- und Kundensegmentierungsprozessen. Lead des Management-Teams Austria und des Brand Teams Ferinject<sup>\u00ae.<\/sup>. Life cycle management des Marktf\u00fchrers im Markt \u201cEisensubstitution i.v.\u201d, \u201cFerinject<sup>\u00ae<\/sup>\u201d (Eisencarboxymaltose), Uro\/Broncho-Vaxom<sup>\u00ae<\/sup>, Launch von Vel-phoro<sup>\u00ae<\/sup> (Sucroferric Oxyhydroxid).<\/td><\/tr><tr><td><strong>09\/2008-01\/2011<\/strong><\/td><td><strong>Daiichi Sankyo Austria, Wien; <em>Head of Product Management<\/em><\/strong><em><\/em> Verantwortung f\u00fcr Marketing, Sales Hospital &amp; Scientific Affairs. Mitglied des Management-Teams. Management von Projekten in den Bereichen Kardiologie, Osteoporose und Gyn\u00e4kologie.Vorbereitung und Launch des Blockbusters \u201eEfient<sup>\u00ae<\/sup>\u201c (Prasugrel) im Rahmen eines interdisziplin\u00e4ren Teams (Brand Team Lead) gemeinsam mit Eli Lilly, Relaunch von \u201eEvista<sup>\u00ae<\/sup>\u201d (Raloxifen), Launch von Sevikar<sup>\u00ae<\/sup>.<\/td><\/tr><tr><td><strong>12\/2007- 08\/2008<\/strong><\/td><td><strong>Donau Chemie, Wien; <em>Key Account Manager<\/em><\/strong> Verantwortung f\u00fcr die Bereiche Marketing &amp; Sales (Consumer Products).<strong><u><\/u><\/strong><\/td><\/tr><tr><td><strong>09\/2006- 02\/2007<\/strong><\/td><td><strong>Johnson&amp;Johnson, Wien; <em>Marketing &amp; Sales Manager Cordis<\/em><\/strong><sup>\u00ae<\/sup><strong> <\/strong><strong><\/strong> Verantwortung f\u00fcr die Bereiche Marketing &amp; Sales der Abteilung Cordis<sup>\u00ae<\/sup> Endovascular. Launch der Medizinprodukte \u201cFrontrunner<sup>\u00ae<\/sup>\u201d und \u201cOutback<sup>\u00ae<\/sup>\u201d in \u00d6sterreich.<strong><u><\/u><\/strong><\/td><\/tr><tr><td><strong>06\/2006- 08\/2006<\/strong><\/td><td><strong>3M ESPE Austria, Perchtoldsdorf; <em>Marketing &amp; Sales Manager<\/em><\/strong> Verantwortung Marketing &amp; Sales Medizintechnik der Dental-Unit 3M ESPE.<strong><u><\/u><\/strong><\/td><\/tr><tr><td><strong>09\/2002- 05\/2006<\/strong><\/td><td><strong>Abbott, Wien; <em>Business Unit Manager Immunology<\/em><\/strong><em><\/em> Verantwortung f\u00fcr die Bereiche Marketing &amp; Sales der BU \u201eHUMIRA\u201c. Marketing\/PR-Projekte im Therapiebereich Rheumatoide Arthritis.<strong><em>Pre-Launch, Launch &amp; Life Cycle Management von \u201eHUMIRA<sup>\u00ae<\/sup>\u201c.<\/em><\/strong><strong><u><\/u><\/strong><\/td><\/tr><tr><td><strong>12\/<\/strong><strong>1999- 08\/2002<\/strong><strong><\/strong><\/td><td><strong>Aesca;<\/strong><strong> Traiskirchen;<\/strong><strong> <em>Medical Manager Marketing<\/em><\/strong><strong><\/strong> Management und Entwicklung nationaler und internationaler klinischer Studien sowie Marketingprojekte.<strong><\/strong><\/td><\/tr><tr><td><strong>12\/1998- 12\/1999<\/strong><strong><\/strong><\/td><td><strong>Eli Lilly, Wien\/EMEA; <\/strong><strong><em>Clinical Research Associate<\/em><\/strong><strong><\/strong> Planung, Implementierung, Monitoring und Auswertung klinischer Studien f\u00fcr Pharmaprodukte in Osteuropa \/ naher Osten \/ Nordafrika (EMEA).<\/td><\/tr><tr><td><strong>05\/1996\u201312\/1998<\/strong><\/td><td><strong>Donau-Universit\u00e4t, Krems; <\/strong><strong><em>Head of Polymer Research<\/em><\/strong> Projektmanagement staatlich\/privat gef\u00f6rderter Forschungsprojekte (FWF, FFF), wissenschaftliche chemische Synthese.<strong><\/strong><\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<p class=\"has-green-color has-text-color has-medium-font-size\"><strong>Ausbildung<\/strong><\/p>\n\n\n\n<figure class=\"wp-block-table\"><table><tbody><tr><td><strong>1996-2000<\/strong><\/td><td><strong>Doktoratsstudium der Technischen Chemie (TU Wien)<\/strong> in Kooperation mit dem Zentrum f\u00fcr Biomedizinische Technologie\/Donau-Universit\u00e4t Krems. Spezialisierung im Bereich Biomedizinische Technologie.These:&nbsp; <em>\u201eSucrosemethacrylates as Adsorbents for Biomedical Applications\u201c<\/em> Abschluss: Oktober 1999<\/td><\/tr><tr><td><strong>1988-1996<\/strong><\/td><td><strong>Diplomstudium der Technischen Chemie (TU Wien)<\/strong> Studium der Technischen Chemie, Studienzweig Bio- und Lebensmittelchemie an der TU Wien; Spezialisierung im Bereich Polymerchemie.These:&nbsp; \u201e<em>Synthesis of new Polybutadiene-Copolymers\u201c<\/em> Abschluss: April 1996<\/td><\/tr><tr><td><strong>1979-1987<\/strong><strong><\/strong><\/td><td><strong>Matura \u201ecum laude\u201c (AHS Kundmanngasse, Wien 3)<\/strong> Humanistisches GymnasiumAbschluss: Juni 1987<strong><\/strong><\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<p class=\"has-green-color has-text-color has-medium-font-size\"><strong>Weiterbildung<\/strong><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Best Practice in Marketing: Management Focus Group \u201eStorytelling in Marketing &amp; Sales\u201c <\/strong>(University of St. Gallen, October\/November 2015); <em><u>Thema: Entwicklung von Stories zur Awareness- und Brand-Bildung.<\/u><\/em><strong><em><\/em><\/strong><\/li>\n\n\n\n<li><strong>Wissenswertes zum Thema \u201eErstattung\u201c: Vorbereitung eines Antrags zur Aufnahme in den EKO <\/strong>(PHARMIG Academy, Oktober 2008); <em><u>Thema:<\/u><\/em> <em>Vorbereitung von Erstattungsunterlagen f\u00fcr Arzneispezialit\u00e4ten.<\/em><\/li>\n\n\n\n<li><strong><em>Quantitative<\/em><\/strong><strong> und qualitative Marktforschung<\/strong> (HCC Consulting, Februar 2006); <em><u>Thema: Marktforschung<\/u><\/em><\/li>\n\n\n\n<li><strong>Die Pharma-Gesetze mu\u00df man kennen <\/strong>(HCC Consulting, Oktober 2005); <em><u>Thema: Verhaltenscodex, AMG<\/u><\/em><\/li>\n\n\n\n<li><strong><em>Grundlagen<\/em><\/strong><strong> von F\u00fchrung und Management <\/strong>(Hernstein Management Institute, April 2005); <em><u>Thema: Leadership &amp; Management<\/u><\/em><\/li>\n\n\n\n<li><strong><em>Customer<\/em><\/strong><strong> Marketing &#8211; Kunden gewinnen und pflegen<\/strong> (WIFI Vienna, April 2002); <em><u>Thema: Customer Marketing<\/u><\/em><\/li>\n\n\n\n<li><strong><em>Medizinische<\/em><\/strong><strong> Datenbanken\/Internet<\/strong> (\u00c4K N\u00d6, Donau-Universit\u00e4t Krems, Dez. 2000); <em><u>Thema: Medizinische Informationssuche<\/u><\/em>&nbsp;<\/li>\n<\/ul>\n\n\n\n<p class=\"has-green-color has-text-color has-medium-font-size\"><strong>Fremdsprachen<\/strong><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Englisch (verhandlungssicher)<\/li>\n\n\n\n<li>Italienisch (Grundkenntnisse)<\/li>\n\n\n\n<li>Deutsch (Muttersprache)<\/li>\n<\/ul>\n\n\n\n<p class=\"has-green-color has-text-color has-medium-font-size\"><strong>Weitere Angaben<\/strong><\/p>\n\n\n\n<p><strong>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Non-Profit-Aktivit\u00e4ten<\/strong><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Permanentes Mitglied der <em><strong>Medieninitiative Digitale Medizin<\/strong><\/em>, 2023-ongoing.<\/li>\n\n\n\n<li>Sprecher der Korporativen Mitglieder,<strong><em> \u00d6sterreichische Gesellschaft f\u00fcr Innere Medizin (\u00d6GIM)<\/em><\/strong>, 01\/2016-08\/2018.<\/li>\n\n\n\n<li>Controller, <strong><em>Hepatitis Hilfe \u00d6sterreich (HH\u00d6)<\/em><\/strong>, 2000-2005.<\/li>\n\n\n\n<li>Schulsprecher, Bundesgymnasium Wien III, Kundmanngasse 22, 1985-1987.<\/li>\n<\/ul>\n\n\n\n<p><strong>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <\/strong><strong>Spezielle Interessen<\/strong><strong><\/strong><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Sport (Wandern), Reisen, Literatur, Musik, Fotografie, Geschichte, Finanzen, IT.<\/li>\n<\/ul>\n\n\n\n<p><strong>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <\/strong><strong>Mitgliedschaften<\/strong><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>TU Vienna Alumni Club<\/li>\n\n\n\n<li>Unteroffiziersgesellschaft N\u00d6<\/li>\n<\/ul>\n\n\n\n<p class=\"has-green-color has-text-color has-medium-font-size\"><strong>Wissenschaftliche Beitr\u00e4ge<\/strong><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><em>Modified Sucrosemethacrylates- New Polymers for Extracorporeal Blood Purification<\/em>, W.A. Gollneritsch, S. Knaus, H. Gruber, I. Linsberger, D. Falkenhagen; XI. World Congress of the International Society for Artificial Organs (ISAO), Providence, 1997 (invited lecture).<\/li>\n\n\n\n<li><em>Hydrogels Based on Sucrosemethacrylates for Biomedical Applications<\/em>, W.A. Gollneritsch, S. Knaus, H. Gruber, I. Linsberger, D. Falkenhagen; XII. Congress of the International Society for Artificial Cells, Blood Substitutes and Immobilization Technology (ISABI), Peking, 1997 (invited lecture).<\/li>\n\n\n\n<li><em>A new procedure in life-support therapy based on a plasma-fractionating membrane<\/em>, D. Falkenhagen, W. Strobl, G. Vogt, A. Schrefl, W. Gollneritsch, I. Linsberger, Technology Conference &#8222;Biomedicine\/Biomedical Technology&#8220;, Rostock, 1997 (Poster).<\/li>\n\n\n\n<li><em>Optimization of combined membrane-adsorbent systems for extracorporeal blood purification<\/em>, D. Falkenhagen, W. Strobl, W. Gollneritsch, R. Mitteregger, G. Vogt, H. Schima, F. Loth, M. Schoenhofen, 42nd ICB Seminar &#8222;Medical Applications of Artificial Membranes, immunoprotection of cells and Bioartificial Organs&#8220;, Warschau, 8.-12. Dez., 1997 (invited lecture).<\/li>\n\n\n\n<li><em>Ein neues Verfahren der Lebensunterst\u00fctzungstherapie auf der Basis einer Plasma-Fraktionierungs-Membran,<\/em> D. Falkenhagen, W. Strobl, G. Vogt, H. Schrefl, W. Gollneritsch, I. Linsberger, Zentrum f\u00fcr Biomedizinische Technologie, Krems an der Donau, Austria); Technologiekonferenz Biomedizin \/ Biomedizintechnik&#8220;, 7.-8.11.1997, Mecklenburg-Vorpommern (Poster).<\/li>\n<\/ul>\n\n\n\n<p class=\"has-green-color has-text-color has-medium-font-size\"><strong>Publikationen<\/strong><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><em>Modified Sucrosemethacrylates- New Polymers for Extracorporeal Blood Purification, W.A. Gollneritsch, S. Knaus, H. Gruber, I. Linsberger, D. Falkenhagen; Artificial Organs 21, 6, p. 559, 1997.<\/em><\/li>\n\n\n\n<li><em>Modifizierte Saccharosemethacrylate &#8211; Neue Materialien f\u00fcr die Extrakorporale Blutreinigung, S. Knaus, W.A. Gollneritsch, H. Gruber, R. Mitteregger I. Linsberger, D. Falkenhagen, \u201eChemie nachwachsender Rohstoffe&#8220;, Bundesministerium f. Umwelt, Jugend und Familie (Hrsg.), Tagungsband zu 26. GDCH-Hauptversammlung und 100-Jahrfeier der G\u00d6CH, 70-74, 1997.<\/em> <\/li>\n\n\n\n<li><em>Interaction of a Bacterial Endotoxin with Different Surfaces Investigated by in Situ Fourier Transform Infrared Attenuated Total Reflection Spectroscopy, G. Reiter, M. Siam, D. Falkenhagen, W. Gollneritsch, D. Baurecht and U.P. Fringeli, Langmuir, 18(15), 5761-5771, 2002.<\/em><\/li>\n<\/ul>\n\n\n\n<hr class=\"wp-block-separator aligncenter has-text-color has-green-color has-alpha-channel-opacity has-green-background-color has-background is-style-wide\"\/>\n","protected":false},"excerpt":{"rendered":"<p>Berufsbild Meine Erfahrung umfasst insbesonders: Beruflicher Werdegang 06\/2023- Daiichi-Sankyo Europe, Evidence Generation (EG), PMOE (Europe); Project Manager (Contractor)Operational Excellence f\u00fcr das Center of Excellence\/Evidence Generation. Entwicklung, Implementierung und Optimierung von Business-Projekten. 06\/2022-07\/2023 IBM\/Pfizer; Bold Moves Team Lead (Contractor)Verantwortung f\u00fcr das Projektmanagement in der Implementierung von PfizerPro (digital engagement platform f\u00fcr HCP). Team Lead f\u00fcr 10 &hellip; <a href=\"https:\/\/gollneritsch.at\/?page_id=251\" class=\"more-link\">Continue reading <span class=\"screen-reader-text\">Pers\u00f6nliche Informationen<\/span> <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"page-templates\/full-width.php","meta":{"ngg_post_thumbnail":0,"footnotes":""},"class_list":["post-251","page","type-page","status-publish","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v24.7 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Pers\u00f6nliche Informationen - gollneritsch.at<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/gollneritsch.at\/?page_id=251\" \/>\n<meta property=\"og:locale\" content=\"de_DE\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Pers\u00f6nliche Informationen - gollneritsch.at\" \/>\n<meta property=\"og:description\" content=\"Berufsbild Meine Erfahrung umfasst insbesonders: Beruflicher Werdegang 06\/2023- Daiichi-Sankyo Europe, Evidence Generation (EG), PMOE (Europe); Project Manager (Contractor)Operational Excellence f\u00fcr das Center of Excellence\/Evidence Generation. Entwicklung, Implementierung und Optimierung von Business-Projekten. 06\/2022-07\/2023 IBM\/Pfizer; Bold Moves Team Lead (Contractor)Verantwortung f\u00fcr das Projektmanagement in der Implementierung von PfizerPro (digital engagement platform f\u00fcr HCP). Team Lead f\u00fcr 10 &hellip; Continue reading Pers\u00f6nliche Informationen &rarr;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/gollneritsch.at\/?page_id=251\" \/>\n<meta property=\"og:site_name\" content=\"gollneritsch.at\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/gollneritsch.at\" \/>\n<meta property=\"article:modified_time\" content=\"2024-05-15T18:15:09+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/gollneritsch.at\/wp-content\/uploads\/2020\/05\/Wolfgang-Gollneritsch_2019-683x1024.jpg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:site\" content=\"@Flughund1969\" \/>\n<meta name=\"twitter:label1\" content=\"Gesch\u00e4tzte Lesezeit\" \/>\n\t<meta name=\"twitter:data1\" content=\"6 Minuten\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/gollneritsch.at\/?page_id=251\",\"url\":\"https:\/\/gollneritsch.at\/?page_id=251\",\"name\":\"Pers\u00f6nliche Informationen - gollneritsch.at\",\"isPartOf\":{\"@id\":\"https:\/\/gollneritsch.at\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/gollneritsch.at\/?page_id=251#primaryimage\"},\"image\":{\"@id\":\"https:\/\/gollneritsch.at\/?page_id=251#primaryimage\"},\"thumbnailUrl\":\"https:\/\/gollneritsch.at\/wp-content\/uploads\/2020\/05\/Wolfgang-Gollneritsch_2019-683x1024.jpg\",\"datePublished\":\"2020-05-28T20:06:06+00:00\",\"dateModified\":\"2024-05-15T18:15:09+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/gollneritsch.at\/?page_id=251#breadcrumb\"},\"inLanguage\":\"de-AT\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/gollneritsch.at\/?page_id=251\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"de-AT\",\"@id\":\"https:\/\/gollneritsch.at\/?page_id=251#primaryimage\",\"url\":\"https:\/\/gollneritsch.at\/wp-content\/uploads\/2020\/05\/Wolfgang-Gollneritsch_2019.jpg\",\"contentUrl\":\"https:\/\/gollneritsch.at\/wp-content\/uploads\/2020\/05\/Wolfgang-Gollneritsch_2019.jpg\",\"width\":1080,\"height\":1620},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/gollneritsch.at\/?page_id=251#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\/\/gollneritsch.at\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Pers\u00f6nliche Informationen\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/gollneritsch.at\/#website\",\"url\":\"https:\/\/gollneritsch.at\/\",\"name\":\"gollneritsch.at\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/gollneritsch.at\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"de-AT\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Pers\u00f6nliche Informationen - gollneritsch.at","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/gollneritsch.at\/?page_id=251","og_locale":"de_DE","og_type":"article","og_title":"Pers\u00f6nliche Informationen - gollneritsch.at","og_description":"Berufsbild Meine Erfahrung umfasst insbesonders: Beruflicher Werdegang 06\/2023- Daiichi-Sankyo Europe, Evidence Generation (EG), PMOE (Europe); Project Manager (Contractor)Operational Excellence f\u00fcr das Center of Excellence\/Evidence Generation. Entwicklung, Implementierung und Optimierung von Business-Projekten. 06\/2022-07\/2023 IBM\/Pfizer; Bold Moves Team Lead (Contractor)Verantwortung f\u00fcr das Projektmanagement in der Implementierung von PfizerPro (digital engagement platform f\u00fcr HCP). Team Lead f\u00fcr 10 &hellip; Continue reading Pers\u00f6nliche Informationen &rarr;","og_url":"https:\/\/gollneritsch.at\/?page_id=251","og_site_name":"gollneritsch.at","article_publisher":"https:\/\/www.facebook.com\/gollneritsch.at","article_modified_time":"2024-05-15T18:15:09+00:00","og_image":[{"url":"https:\/\/gollneritsch.at\/wp-content\/uploads\/2020\/05\/Wolfgang-Gollneritsch_2019-683x1024.jpg","type":"","width":"","height":""}],"twitter_card":"summary_large_image","twitter_site":"@Flughund1969","twitter_misc":{"Gesch\u00e4tzte Lesezeit":"6 Minuten"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/gollneritsch.at\/?page_id=251","url":"https:\/\/gollneritsch.at\/?page_id=251","name":"Pers\u00f6nliche Informationen - gollneritsch.at","isPartOf":{"@id":"https:\/\/gollneritsch.at\/#website"},"primaryImageOfPage":{"@id":"https:\/\/gollneritsch.at\/?page_id=251#primaryimage"},"image":{"@id":"https:\/\/gollneritsch.at\/?page_id=251#primaryimage"},"thumbnailUrl":"https:\/\/gollneritsch.at\/wp-content\/uploads\/2020\/05\/Wolfgang-Gollneritsch_2019-683x1024.jpg","datePublished":"2020-05-28T20:06:06+00:00","dateModified":"2024-05-15T18:15:09+00:00","breadcrumb":{"@id":"https:\/\/gollneritsch.at\/?page_id=251#breadcrumb"},"inLanguage":"de-AT","potentialAction":[{"@type":"ReadAction","target":["https:\/\/gollneritsch.at\/?page_id=251"]}]},{"@type":"ImageObject","inLanguage":"de-AT","@id":"https:\/\/gollneritsch.at\/?page_id=251#primaryimage","url":"https:\/\/gollneritsch.at\/wp-content\/uploads\/2020\/05\/Wolfgang-Gollneritsch_2019.jpg","contentUrl":"https:\/\/gollneritsch.at\/wp-content\/uploads\/2020\/05\/Wolfgang-Gollneritsch_2019.jpg","width":1080,"height":1620},{"@type":"BreadcrumbList","@id":"https:\/\/gollneritsch.at\/?page_id=251#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/gollneritsch.at\/"},{"@type":"ListItem","position":2,"name":"Pers\u00f6nliche Informationen"}]},{"@type":"WebSite","@id":"https:\/\/gollneritsch.at\/#website","url":"https:\/\/gollneritsch.at\/","name":"gollneritsch.at","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/gollneritsch.at\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"de-AT"}]}},"_links":{"self":[{"href":"https:\/\/gollneritsch.at\/index.php?rest_route=\/wp\/v2\/pages\/251","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/gollneritsch.at\/index.php?rest_route=\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/gollneritsch.at\/index.php?rest_route=\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/gollneritsch.at\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/gollneritsch.at\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=251"}],"version-history":[{"count":19,"href":"https:\/\/gollneritsch.at\/index.php?rest_route=\/wp\/v2\/pages\/251\/revisions"}],"predecessor-version":[{"id":1143,"href":"https:\/\/gollneritsch.at\/index.php?rest_route=\/wp\/v2\/pages\/251\/revisions\/1143"}],"wp:attachment":[{"href":"https:\/\/gollneritsch.at\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=251"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}